<?xml version="1.0" encoding="iso-8859-1" ?>
<newsitem itemid="5526" id="root" date="1996-08-21" xml:lang="en">
<title>USA: RESEARCH ALERT - Bausch &amp; Lomb kept at hold.</title>
<headline>RESEARCH ALERT - Bausch &amp; Lomb kept at hold.</headline>
<text>
<p>-- Salomon Brothers analyst Eli Kammerman said he maintained his hold rating on Bausch &amp; Lomb Inc and maintained estimates of $2.40 per share for 1996 and $2.70 for 1997.</p>
<p>-- believes current stock weakness is due to approval by U.S. Food and Drug Aministration of cochlear implant, seen as improved technology compared to traditional hearing aid, including Bausch's Miracle Ear.</p>
<p>-- sees sales growth from Bausch's Miracle Ear division likely to slow from his estimate of 8 percent annually to 4-6 percent.</p>
<p>-- Bausch shares fell 2-1/2 to 33-1/2.</p>
</text>
<copyright>(c) Reuters Limited 1996</copyright>
<metadata>
<codes class="bip:countries:1.0">
  <code code="USA">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1996-08-21"/>
  </code>
</codes>
<codes class="bip:industries:1.0">
  <code code="I37300">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1996-08-21"/>
  </code>
</codes>
<codes class="bip:topics:1.0">
  <code code="C15">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1996-08-21"/>
  </code>
  <code code="C152">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1996-08-21"/>
  </code>
  <code code="CCAT">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1996-08-21"/>
  </code>
</codes>
<dc element="dc.publisher" value="Reuters Holdings Plc"/>
<dc element="dc.date.published" value="1996-08-21"/>
<dc element="dc.source" value="Reuters"/>
<dc element="dc.creator.location.country.name" value="USA"/>
<dc element="dc.source" value="Reuters"/>
</metadata>
</newsitem>
